{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:40:34Z","timestamp":1784281234014,"version":"3.55.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tehran University of Medical Sciences (TUMS), International Campus (TUMS-IC), and the Neuroscience Institute, MS Research Centre, TUMS, Tehran, Iran","award":["1400-2-99-54526"],"award-info":[{"award-number":["1400-2-99-54526"]}]},{"name":"Tehran University of Medical Sciences (TUMS), International Campus (TUMS-IC), and the Neuroscience Institute, MS Research Centre, TUMS, Tehran, Iran","award":["1400-2-99-54526"],"award-info":[{"award-number":["1400-2-99-54526"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-025-09734-2","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:34:27Z","timestamp":1770946467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4223-2788","authenticated-orcid":false,"given":"Mansur","family":"Aliyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8612-4773","authenticated-orcid":false,"given":"Ali Akbar","family":"Saboor-Yaraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-8807","authenticated-orcid":false,"given":"Mohamad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-0048","authenticated-orcid":false,"given":"Farshid","family":"Noorbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-4730","authenticated-orcid":false,"given":"Al-Mukhtar Yahuza","family":"Adamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-0927","authenticated-orcid":false,"given":"Alhassan Abdullahi","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2181-9180","authenticated-orcid":false,"given":"Zainab Aliyu","family":"Abdulqadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"1","key":"9734_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"G Comi","year":"2021","unstructured":"Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X, et al. Role of B cells in multiple sclerosis and related disorders. Ann Neurol. 2021;89(1):13\u201323. https:\/\/doi.org\/10.1002\/ana.25927.","journal-title":"Ann Neurol"},{"issue":"3536","key":"9734_CR2","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20330","volume":"150","author":"I Jelcic","year":"2020","unstructured":"Jelcic I, Sospedra M, Martin R. When a T cell engages a B cell: novel insights in multiple sclerosis. Swiss Med Wkly. 2020;150(3536):w20330-w. https:\/\/doi.org\/10.4414\/smw.2020.20330.","journal-title":"Swiss Med Wkly"},{"key":"9734_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00760","volume":"11","author":"J van Langelaar","year":"2020","unstructured":"van Langelaar J, Rijvers L, Smolders J, van Luijn MM. B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers. Front Immunol. 2020;11:760. https:\/\/doi.org\/10.3389\/fimmu.2020.00760.","journal-title":"Front Immunol"},{"key":"9734_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2022-001919","author":"P Zheng","year":"2023","unstructured":"Zheng P, Xiu Y, Chen Z, Yuan M, Li Y, Wang N, et al. Group 2 innate lymphoid cells resolve neuroinflammation following cerebral ischaemia. Stroke Vasc Neurol. 2023. https:\/\/doi.org\/10.1136\/svn-2022-001919.","journal-title":"Stroke Vasc Neurol"},{"issue":"12","key":"9734_CR5","doi-asserted-by":"publisher","first-page":"e1426","DOI":"10.1002\/cti2.1426","volume":"11","author":"F Aglas-Leitner","year":"2022","unstructured":"Aglas-Leitner F, Juillard P, Juillard A, Byrne SN, Hawke S, Grau GE, et al. Circulating CCR6(+)ILC proportions are lower in multiple sclerosis patients. Clin Transl Immunol. 2022;11(12):e1426. https:\/\/doi.org\/10.1002\/cti2.1426.","journal-title":"Clin Transl Immunol"},{"issue":"3","key":"9734_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","volume":"29","author":"AK Savage","year":"2008","unstructured":"Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B, et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 2008;29(3):391\u2013403. https:\/\/doi.org\/10.1016\/j.immuni.2008.07.011.","journal-title":"Immunity"},{"issue":"9","key":"9734_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.1641","volume":"9","author":"D Kovalovsky","year":"2008","unstructured":"Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, Alonzo E, et al. The BTB\u2013zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol. 2008;9(9):1055\u201364. https:\/\/doi.org\/10.1038\/ni.1641.","journal-title":"Nat Immunol"},{"issue":"10","key":"9734_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ni.1930","volume":"11","author":"P Aliahmad","year":"2010","unstructured":"Aliahmad P, de la Torre B, Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue\u2013inducer cell and NK cell lineages. Nat Immunol. 2010;11(10):945\u201352. https:\/\/doi.org\/10.1038\/ni.1930.","journal-title":"Nat Immunol"},{"issue":"7496","key":"9734_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nature13047","volume":"508","author":"MG Constantinides","year":"2014","unstructured":"Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. A committed precursor to innate lymphoid cells. Nature. 2014;508(7496):397\u2013401. https:\/\/doi.org\/10.1038\/nature13047.","journal-title":"Nature"},{"issue":"2","key":"9734_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells\u2014a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145. https:\/\/doi.org\/10.1038\/nri3365.","journal-title":"Nat Rev Immunol"},{"issue":"7230","key":"9734_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722\u20135. https:\/\/doi.org\/10.1038\/nature07537.","journal-title":"Nature"},{"issue":"2","key":"9734_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","volume":"54","author":"K Golebski","year":"2021","unstructured":"Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. 2021;54(2):291\u2013e3077. https:\/\/doi.org\/10.1016\/j.immuni.2020.12.013.","journal-title":"Immunity"},{"issue":"7890","key":"9734_CR13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41586-021-04136-4","volume":"600","author":"JB Grigg","year":"2021","unstructured":"Grigg JB, Shanmugavadivu A, Regen T, Parkhurst CN, Ahmed A, Joseph AM, et al. Antigen-presenting innate lymphoid cells orchestrate neuroinflammation. Nature. 2021;600(7890):707. https:\/\/doi.org\/10.1038\/s41586-021-04136-4.","journal-title":"Nature"},{"issue":"11","key":"9734_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1164\/rccm.202010-3754OC","volume":"204","author":"J Dhariwal","year":"2021","unstructured":"Dhariwal J, Cameron A, Wong E, Paulsen M, Trujillo-Torralbo MB, Del Rosario A, et al. Pulmonary innate lymphoid cell responses during Rhinovirus-induced asthma exacerbations in vivo: A clinical trial. Am J Respir Crit Care Med. 2021;204(11):1259. https:\/\/doi.org\/10.1164\/rccm.202010-3754OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"9734_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101549","volume":"23","author":"S Hirose","year":"2020","unstructured":"Hirose S, Jahani PS, Wang S, Jaggi U, Tormanen K, Yu J, et al. Type 2 innate lymphoid cells induce CNS demyelination in an HSV-IL-2 mouse model of multiple sclerosis. iScience. 2020;23(10):101549. https:\/\/doi.org\/10.1016\/j.isci.2020.101549.","journal-title":"iScience"},{"key":"9734_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1146077","author":"AA Korchagina","year":"2023","unstructured":"Korchagina AA, Shein SA, Koroleva E, Tumanov AV. Transcriptional control of ILC identity. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1146077.","journal-title":"Front Immunol"},{"issue":"6","key":"9734_CR17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41422-020-0323-8","volume":"30","author":"CSN Klose","year":"2020","unstructured":"Klose CSN, Artis D. Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity. Cell Res. 2020;30(6):475. https:\/\/doi.org\/10.1038\/s41422-020-0323-8.","journal-title":"Cell Res"},{"key":"9734_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/17534259241287311","volume":"30","author":"T Yuan","year":"2024","unstructured":"Yuan T, Zhou Q, Tian Y, Ou Y, Long Y, Tan Y. Innate lymphoid cells and infectious diseases. Innate Immun. 2024;30:120. https:\/\/doi.org\/10.1177\/17534259241287311.","journal-title":"Innate Immun"},{"key":"9734_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.914266","author":"M Calvi","year":"2022","unstructured":"Calvi M, Di Vito C, Frigo A, Trabanelli S, Jandus C, Mavilio D. Development of human ILCs and impact of unconventional cytotoxic subsets in the pathophysiology of inflammatory diseases and cancer. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.914266.","journal-title":"Front Immunol"},{"key":"9734_CR20","doi-asserted-by":"publisher","unstructured":"Zhang Y, He J, Li X, Chen H, Yang Z, Wang Y. Dissecting the heterogeneity and tumor-associated dynamics of human liver group I ILC via scrna sequencing data. bioRxiv. 2024:2024.10.24.619932. https:\/\/doi.org\/10.1101\/2024.10.24.619932.","DOI":"10.1101\/2024.10.24.619932"},{"issue":"9","key":"9734_CR21","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41423-022-00901-1","volume":"19","author":"S Curio","year":"2022","unstructured":"Curio S, Belz GT. The unique role of innate lymphoid cells in cancer and the hepatic microenvironment. Cell Mol Immunol. 2022;19(9):1012\u201329. https:\/\/doi.org\/10.1038\/s41423-022-00901-1.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"9734_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.it.2022.04.009","volume":"43","author":"J-H Schroeder","year":"2022","unstructured":"Schroeder J-H, Howard JK, Lord GM. Transcription factor-driven regulation of ILC1 and ILC3. Trends Immunol. 2022;43(7):564\u201379. https:\/\/doi.org\/10.1016\/j.it.2022.04.009.","journal-title":"Trends Immunol"},{"issue":"4","key":"9734_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13238-017-0369-7","volume":"8","author":"C Zhong","year":"2017","unstructured":"Zhong C, Zhu J. Transcriptional regulators dictate innate lymphoid cell fates. Protein Cell. 2017;8(4):242\u2013. https:\/\/doi.org\/10.1007\/s13238-017-0369-7. 54.","journal-title":"Protein Cell"},{"issue":"1","key":"9734_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","volume":"171","author":"S Wang","year":"2017","unstructured":"Wang S, Xia P, Chen Y, Qu Y, Xiong Z, Ye B, et al. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell. 2017;171(1):201\u2013. https:\/\/doi.org\/10.1016\/j.cell.2017.07.027. 16.e18.","journal-title":"Cell"},{"key":"9734_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coi.2019.11.005","volume":"62","author":"JW McGinty","year":"2020","unstructured":"McGinty JW, von Moltke J. A three course menu for ILC and bystander T cell activation. Curr Opin Immunol. 2020;62:15\u201321. https:\/\/doi.org\/10.1016\/j.coi.2019.11.005.","journal-title":"Curr Opin Immunol"},{"key":"9734_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789788","volume":"12","author":"AS Clottu","year":"2022","unstructured":"Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate lymphoid cells in autoimmune diseases. Front Immunol. 2022;12:789788. https:\/\/doi.org\/10.3389\/fimmu.2021.789788.","journal-title":"Front Immunol"},{"issue":"3","key":"9734_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.33696\/cancerimmunol.6.093","volume":"6","author":"Z Hassouneh","year":"2024","unstructured":"Hassouneh Z, Huang G, Zhang N, Rao M, Mukherjee N. Commentary: on the emerging role of innate lymphoid cells in bladder cancer. J Cancer Immunol. 2024;6(3):125\u201334. https:\/\/doi.org\/10.33696\/cancerimmunol.6.093.","journal-title":"J Cancer Immunol"},{"issue":"5","key":"9734_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.14348\/molcells.2021.0053","volume":"44","author":"J Kim","year":"2021","unstructured":"Kim J, Ryu S, Kim HY. Innate lymphoid cells in tissue homeostasis and disease pathogenesis. Mol Cells. 2021;44(5):301\u20139. https:\/\/doi.org\/10.14348\/molcells.2021.0053.","journal-title":"Mol Cells"},{"key":"9734_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1364485","author":"D Kve\u0161tak","year":"2024","unstructured":"Kve\u0161tak D, Mihali\u0107 A, Jonji\u0107 S, Brizi\u0107 I. Innate lymphoid cells in neuroinflammation. Front Cell Neurosci. 2024. https:\/\/doi.org\/10.3389\/fncel.2024.1364485.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"9734_CR30","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.1501491","volume":"196","author":"F Roan","year":"2016","unstructured":"Roan F, Stoklasek TA, Whalen E, Molitor JA, Bluestone JA, Buckner JH, et al. CD4+group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J Immunol. 2016;196(5):2051\u201362. https:\/\/doi.org\/10.4049\/jimmunol.1501491.","journal-title":"J Immunol"},{"issue":"8","key":"9734_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DAA Vignali","year":"2012","unstructured":"Vignali DAA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722\u20138. https:\/\/doi.org\/10.1038\/ni.2366.","journal-title":"Nat Immunol"},{"issue":"1","key":"9734_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00705-1","volume":"6","author":"TM Conlon","year":"2021","unstructured":"Conlon TM, Knolle PA, Yildirim A\u00d6. Local tissue development of type 1 innate lymphoid cells: guided by interferon-gamma. Signal Transduct Target Ther. 2021;6(1):287. https:\/\/doi.org\/10.1038\/s41392-021-00705-1.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"9734_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1445-5994.1995.tb02883.x","volume":"25","author":"JA Trapani","year":"1995","unstructured":"Trapani JA. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B. Aust N Z J Med. 1995;25(6):793\u20139. https:\/\/doi.org\/10.1111\/j.1445-5994.1995.tb02883.x.","journal-title":"Aust N Z J Med"},{"issue":"3","key":"9734_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202100281","volume":"44","author":"J Zhang","year":"2022","unstructured":"Zhang J, Rousseaux N, Walzer E. Eomes and T-bet, a dynamic duo regulating NK cell differentiation. Bioessays. 2022;44(3):2100281. https:\/\/doi.org\/10.1002\/bies.202100281.","journal-title":"Bioessays"},{"issue":"Pt 9","key":"9734_CR35","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awh219","volume":"127","author":"K Takahashi","year":"2004","unstructured":"Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T. The regulatory role of natural killer cells in multiple sclerosis. Brain. 2004;127(Pt 9):1917\u201327. https:\/\/doi.org\/10.1093\/brain\/awh219.","journal-title":"Brain"},{"key":"9734_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1500770","volume":"19","author":"F Aghaee","year":"2025","unstructured":"Aghaee F, Abedinpour M, Anvari S, Saberi A, Fallah A, Bakhshi A. Natural killer cells in multiple sclerosis: foe or friends? Front Cell Neurosci. 2025;19:1500770. https:\/\/doi.org\/10.3389\/fncel.2025.1500770.","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"9734_CR37","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.4049\/jimmunol.161.7.3493","volume":"161","author":"L Azzoni","year":"1998","unstructured":"Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B. Differential transcriptional regulation of CD161 and a novel gene, 197\/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol. 1998;161(7):3493\u2013500. https:\/\/doi.org\/10.4049\/jimmunol.161.7.3493.","journal-title":"J Immunol"},{"issue":"4","key":"9734_CR38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/eji.202048696","volume":"51","author":"L Krabbendam","year":"2021","unstructured":"Krabbendam L, Heesters BA, Kradolfer CM, Spits H, Bernink JH. Identification of human cytotoxic ILC3s. Eur J Immunol. 2021;51(4):811\u201323. https:\/\/doi.org\/10.1002\/eji.202048696.","journal-title":"Eur J Immunol"},{"issue":"6263","key":"9734_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","volume":"350","author":"G Gasteiger","year":"2015","unstructured":"Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Sci (New York NY). 2015;350(6263):981\u20135. https:\/\/doi.org\/10.1126\/science.aac9593.","journal-title":"Sci (New York NY)"},{"issue":"5","key":"9734_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41422-020-00445-x","volume":"31","author":"L Mazzurana","year":"2021","unstructured":"Mazzurana L, Czarnewski P, Jonsson V, Wigge L, Ringn\u00e9r M, Williams TC, et al. Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing. Cell Res. 2021;31(5):554\u201368. https:\/\/doi.org\/10.1038\/s41422-020-00445-x.","journal-title":"Cell Res"},{"issue":"1","key":"9734_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-019-0330-z","volume":"20","author":"PT Mantani","year":"2019","unstructured":"Mantani PT, Dun\u00e9r P, Ljungcrantz I, Nilsson J, Bj\u00f6rkbacka H, Fredrikson GN. ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions. BMC Immunol. 2019;20(1):47. https:\/\/doi.org\/10.1186\/s12865-019-0330-z.","journal-title":"BMC Immunol"},{"issue":"3","key":"9734_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ila2.59","volume":"2","author":"L Cui","year":"2024","unstructured":"Cui L, Wang Y. Regulatory factors of ILC2 are therapeutic targets for lung inflammation. iLABMED. 2024;2(3):205\u201320. https:\/\/doi.org\/10.1002\/ila2.59.","journal-title":"iLABMED"},{"issue":"7671","key":"9734_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature23469","volume":"549","author":"V Cardoso","year":"2017","unstructured":"Cardoso V, Chesn\u00e9 J, Ribeiro H, Garc\u00eda-Cassani B, Carvalho T, Bouchery T, et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. Nature. 2017;549(7671):277\u201381. https:\/\/doi.org\/10.1038\/nature23469.","journal-title":"Nature"},{"key":"9734_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01252","author":"T Perchet","year":"2018","unstructured":"Perchet T, Petit M, Banchi E-G, Meunier S, Cumano A, Golub R. The notch signaling pathway is balancing type 1 innate lymphoid cell immune functions. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01252.","journal-title":"Front Immunol"},{"issue":"98","key":"9734_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade7530","volume":"9","author":"LP Araujo","year":"2024","unstructured":"Araujo LP, Edwards M, Irie K, Huang Y, Kawano Y, Tran A, et al. Context-dependent role of group 3 innate lymphoid cells in mucosal protection. Sci Immunol. 2024;9(98):eade7530. https:\/\/doi.org\/10.1126\/sciimmunol.ade7530.","journal-title":"Sci Immunol"},{"issue":"2","key":"9734_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cellimm.2015.06.006","volume":"297","author":"JK Hatfield","year":"2015","unstructured":"Hatfield JK, Brown MA. Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE. Cell Immunol. 2015;297(2):69\u201379. https:\/\/doi.org\/10.1016\/j.cellimm.2015.06.006.","journal-title":"Cell Immunol"},{"key":"9734_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657622","author":"\u0110 Miljkovi\u0107","year":"2021","unstructured":"Miljkovi\u0107 \u0110, Jevti\u0107 B, Stojanovi\u0107 I, Dimitrijevi\u0107 M. ILC3, a central innate immune component of the gut-brain axis in multiple sclerosis. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.657622.","journal-title":"Front Immunol"},{"key":"9734_CR48","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e3","author":"J Ham","year":"2025","unstructured":"Ham J, Yang W, Kim HY. Tissue-specific metabolic reprogramming in innate lymphoid cells and its impact on disease. Immune Netw. 2025. https:\/\/doi.org\/10.4110\/in.2025.25.e3.","journal-title":"Immune Netw"},{"issue":"1","key":"9734_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ni.1684","volume":"10","author":"SL Sanos","year":"2009","unstructured":"Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, et al. Ror\u03b3t and commensal microflora are required for the differentiation of mucosal interleukin 22\u2013producing NKp46+ cells. Nat Immunol. 2009;10(1):83\u201391. https:\/\/doi.org\/10.1038\/ni.1684.","journal-title":"Nat Immunol"},{"issue":"3","key":"9734_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3349\/ymj.2008.49.3.352","volume":"49","author":"MY Kim","year":"2008","unstructured":"Kim MY. Roles of embryonic and adult lymphoid tissue inducer cells in primary and secondary lymphoid tissues. Yonsei Med J. 2008;49(3):352\u20136. https:\/\/doi.org\/10.3349\/ymj.2008.49.3.352.","journal-title":"Yonsei Med J"},{"key":"9734_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coi.2014.01.013","volume":"27","author":"MR Hepworth","year":"2014","unstructured":"Hepworth MR, Sonnenberg GF. Regulation of the adaptive immune system by innate lymphoid cells. Curr Opin Immunol. 2014;27:75\u201382. https:\/\/doi.org\/10.1016\/j.coi.2014.01.013.","journal-title":"Curr Opin Immunol"},{"key":"9734_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/cells13040335","author":"M Fol","year":"2024","unstructured":"Fol M, Karpik W, Zablotni A, Kulesza J, Kulesza E, Godkowicz M, et al. Innate lymphoid cells and their role in the immune response to infections. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13040335.","journal-title":"Cells"},{"key":"9734_CR53","doi-asserted-by":"publisher","unstructured":"Luci C, Golub R, Jancic CC, Editorial. Innate lymphoid cells: characterization and classification. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1338463.","DOI":"10.3389\/fimmu.2023.1338463"},{"key":"9734_CR54","doi-asserted-by":"publisher","unstructured":"Mejri O, Ma L, Aoudi A, Labiad O, Mondot S, Igalouzene R et al. Adaptive immunity shapes innate and epithelial cell landscapes by silencing tonic IFN-\u03b3 in innate lymphoid cells during homeostasis. bioRxiv. 2024:2024.09.19.613869. https:\/\/doi.org\/10.1101\/2024.09.19.613869","DOI":"10.1101\/2024.09.19.613869"},{"issue":"3","key":"9734_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"YF Halim Timotheus","year":"2014","unstructured":"Halim Timotheus YF, Steer Catherine A, Math\u00e4 L, Gold Matthew J, Martinez-Gonzalez I, McNagny Kelly M, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 Cell-Mediated allergic lung inflammation. Immunity. 2014;40(3):425\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.011.","journal-title":"Immunity"},{"issue":"1","key":"9734_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ni.3294","volume":"17","author":"TYF Halim","year":"2016","unstructured":"Halim TYF, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 2016;17(1):57\u201364. https:\/\/doi.org\/10.1038\/ni.3294.","journal-title":"Nat Immunol"},{"issue":"6","key":"9734_CR57","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/mi.2016.4","volume":"9","author":"VS Pelly","year":"2016","unstructured":"Pelly VS, Kannan Y, Coomes SM, Entwistle LJ, R\u00fcckerl D, Seddon B, et al. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol. 2016;9(6):1407\u201317. https:\/\/doi.org\/10.1038\/mi.2016.4.","journal-title":"Mucosal Immunol"},{"issue":"7452","key":"9734_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, et al. Innate lymphoid cells regulate CD4+T-cell responses to intestinal commensal bacteria. Nature. 2013;498(7452):113\u20137. https:\/\/doi.org\/10.1038\/nature12240.","journal-title":"Nature"},{"key":"9734_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.909275","volume":"13","author":"N Sadeghi Hassanabadi","year":"2022","unstructured":"Sadeghi Hassanabadi N, Broux B, Marinovi\u0107 S, Gotthardt D. Innate Lymphoid Cells - Neglected Players in Multiple Sclerosis. Front Immunol. 2022;13:909275. https:\/\/doi.org\/10.3389\/fimmu.2022.909275.","journal-title":"Front Immunol"},{"key":"9734_CR60","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91663","author":"PW Lee","year":"2017","unstructured":"Lee PW, Smith AJ, Yang Y, Selhorst AJ, Liu Y, Racke MK, et al. IL-23R\u2013activated STAT3\/STAT4 is essential for Th1\/Th17-mediated CNS autoimmunity. JCI Insight. 2017. https:\/\/doi.org\/10.1172\/jci.insight.91663.","journal-title":"JCI Insight"},{"issue":"10","key":"9734_CR61","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41593-023-01435-z","volume":"26","author":"M Andreadou","year":"2023","unstructured":"Andreadou M, Ingelfinger F, De Feo D, Cramer TLM, Tuzlak S, Friebel E, et al. IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat Neurosci. 2023;26(10):1701\u201312. https:\/\/doi.org\/10.1038\/s41593-023-01435-z.","journal-title":"Nat Neurosci"},{"key":"9734_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.55563\/clinexprheumatol\/hhcnmt","volume":"42","author":"ML Pizzo","year":"2024","unstructured":"Pizzo ML, La Barbera L, Rizzo C, Mohammadnezhad L, Camarda F, Ciccia F, et al. JAK\/STAT Inhibition modifies the ILC1 immune response in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2024;42:593\u2013600. https:\/\/doi.org\/10.55563\/clinexprheumatol\/hhcnmt.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"9734_CR63","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1016\/j.apsb.2023.07.026","volume":"13","author":"S Shao","year":"2023","unstructured":"Shao S, Chen C, Shi G, Zhou Y, Wei Y, Wu L, et al. JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes. Acta Pharm Sin B. 2023;13(10):4185\u2013201. https:\/\/doi.org\/10.1016\/j.apsb.2023.07.026.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"9734_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03017-7","volume":"21","author":"M Lazarevi\u0107","year":"2024","unstructured":"Lazarevi\u0107 M, Stegnjai\u0107 G, Jevti\u0107 B, Despotovi\u0107 S, Ignjatovi\u0107 \u0110, Stanisavljevi\u0107 S, et al. Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity. J Neuroinflammation. 2024;21(1):26. https:\/\/doi.org\/10.1186\/s12974-024-03017-7.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"9734_CR65","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/1352458516662726","volume":"23","author":"CC Gross","year":"2017","unstructured":"Gross CC, Schulte-Mecklenbeck A, Hanning U, Posevitz-Fejf\u00e1r A, Korsukewitz C, Schwab N, et al. Distinct pattern of lesion distribution in multiple sclerosis is associated with different Circulating T-helper and helper-like innate lymphoid cell subsets. Mult Scler J. 2017;23(7):1025\u201330. https:\/\/doi.org\/10.1177\/1352458516662726.","journal-title":"Mult Scler J"},{"issue":"8","key":"9734_CR66","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458515609795","volume":"22","author":"M Degn","year":"2016","unstructured":"Degn M, Modvig S, Dyring-Andersen B, Bonefeld CM, Frederiksen JL, Geisler C, et al. Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis. Mult Scler (Houndmills Basingstoke England). 2016;22(8):1013\u201320. https:\/\/doi.org\/10.1177\/1352458515609795.","journal-title":"Mult Scler (Houndmills Basingstoke England)"},{"issue":"9","key":"9734_CR67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jnen\/nlw063","volume":"75","author":"B Serafini","year":"2016","unstructured":"Serafini B, Rosicarelli B, Veroni C, Zhou L, Reali C, Aloisi F. ROR\u03b3t expression and lymphoid neogenesis in the brain of patients with secondary progressive multiple sclerosis. J Neuropathol Exp Neurol. 2016;75(9):877\u201388. https:\/\/doi.org\/10.1093\/jnen\/nlw063.","journal-title":"J Neuropathol Exp Neurol"},{"key":"9734_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1500-x","volume":"16","author":"V Schropp","year":"2019","unstructured":"Schropp V, Rohde J, Rovituso DM, Jabari S, Bharti R, Kuerten S. Contribution of lti and TH 17 cells to B cell aggregate formation in the central nervous system in a mouse model of multiple sclerosis. J Neuroinflammation. 2019;16:1\u201315. https:\/\/doi.org\/10.1186\/s12974-019-1500-x.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"9734_CR69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/imr.12407","volume":"271","author":"YE Bar-Ephra\u00efm","year":"2016","unstructured":"Bar-Ephra\u00efm YE, Mebius RE. Innate lymphoid cells in secondary lymphoid organs. Immunol Rev. 2016;271(1):185\u201399. https:\/\/doi.org\/10.1111\/imr.12407.","journal-title":"Immunol Rev"},{"issue":"1","key":"9734_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct Target Ther. 2024;9(1):225. https:\/\/doi.org\/10.1038\/s41392-024-01947-5.","journal-title":"Signal Transduct Target Ther"},{"key":"9734_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.607766","author":"A Negron","year":"2020","unstructured":"Negron A, St\u00fcve O, Forsthuber TG. Ectopic lymphoid follicles in multiple sclerosis: centers for disease control? Front Neurol. 2020. https:\/\/doi.org\/10.3389\/fneur.2020.607766.","journal-title":"Front Neurol"},{"issue":"3","key":"9734_CR72","first-page":"168","volume":"13","author":"N Majdinasab","year":"2014","unstructured":"Majdinasab N, Hosseini Behbahani M, Galehdari H, Mohaghegh M. Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan. Iran J Neurol. 2014;13(3):168\u201371.","journal-title":"Iran J Neurol"},{"issue":"Suppl 2","key":"9734_CR73","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1002\/ana.410360807","volume":"36","author":"DG Haegert","year":"1994","unstructured":"Haegert DG, Marrosu MG. Genetic susceptibility to multiple sclerosis. Ann Neurol. 1994;36(Suppl 2):S204\u201310. https:\/\/doi.org\/10.1002\/ana.410360807.","journal-title":"Ann Neurol"},{"issue":"1","key":"9734_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24617-4","volume":"12","author":"FT Aglas-Leitner","year":"2022","unstructured":"Aglas-Leitner FT, Juillard P, Juillard A, Byrne SN, Hawke S, Grau GE, et al. Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis. Sci Rep. 2022;12(1):20411. https:\/\/doi.org\/10.1038\/s41598-022-24617-4.","journal-title":"Sci Rep"},{"key":"9734_CR75","unstructured":"Steinmann SFK. The role of type 2 innate lymphoid cells in the pathogenesis of liver inflammation. Staats-und Universit\u00e4tsbibliothek Hamburg Carl von Ossietzky 2019."},{"issue":"7","key":"9734_CR76","doi-asserted-by":"publisher","first-page":"E1520","DOI":"10.1073\/pnas.1710401115","volume":"115","author":"AE Russi","year":"2018","unstructured":"Russi AE, Ebel ME, Yang Y, Brown MA. Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc Natl Acad Sci USA. 2018;115(7):E1520\u20139. https:\/\/doi.org\/10.1073\/pnas.1710401115.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9734_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57985-w","volume":"10","author":"S Steinmann","year":"2020","unstructured":"Steinmann S, Schoedsack M, Heinrich F, Breda PC, Ochel A, Tiegs G, et al. Hepatic ILC2 activity is regulated by liver inflammation-induced cytokines and effector CD4+ T cells. Sci Rep. 2020;10(1): 1071. https:\/\/doi.org\/10.1038\/s41598-020-57985-w.","journal-title":"Sci Rep"},{"key":"9734_CR78","doi-asserted-by":"publisher","unstructured":"Warren KJ, Wyatt TA. Assessment of lymphocyte migration in an ex vivo transmigration system. J Visualized Experiments: JoVE. 2019;151. https:\/\/doi.org\/10.3791\/60060.","DOI":"10.3791\/60060"},{"issue":"11","key":"9734_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111240","volume":"27","author":"L She","year":"2024","unstructured":"She L, Alanazi HH, Xu Y, Yu Y, Gao Y, Guo S, et al. Direct activation of toll-like receptor 4 signaling in group 2 innate lymphoid cells contributes to inflammatory responses of allergic diseases. iScience. 2024;27(11):111240. https:\/\/doi.org\/10.1016\/j.isci.2024.111240.","journal-title":"iScience"},{"issue":"1","key":"9734_CR80","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.kint.2019.07.019","volume":"97","author":"Q Cao","year":"2020","unstructured":"Cao Q, Wang R, Wang Y, Niu Z, Chen T, Wang C, et al. Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia\/reperfusion injury. Kidney Int. 2020;97(1):130\u201342. https:\/\/doi.org\/10.1016\/j.kint.2019.07.019.","journal-title":"Kidney Int"},{"issue":"3","key":"9734_CR81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0271678X231208168","volume":"44","author":"M Liu","year":"2023","unstructured":"Liu M, Wang D, Xu L, Pan Y, Huang H, Li M, et al. Group 2 innate lymphoid cells suppress neuroinflammation and brain injury following intracerebral hemorrhage. J Cereb Blood Flow Metab. 2023;44(3):355\u201366. https:\/\/doi.org\/10.1177\/0271678X231208168.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"9734_CR82","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W, Huang Y, Zhou R. Nlrp3 inflammasome in neuroinflammation and central nervous system diseases. Cell Mol Immunol. 2025;22(4):341\u201355. https:\/\/doi.org\/10.1038\/s41423-025-01275-w.","journal-title":"Cell Mol Immunol"},{"key":"9734_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cells12212556","author":"N Emami Fard","year":"2023","unstructured":"Emami Fard N, Xiao M, Sehmi R. Regulatory ILC2-role of IL-10 producing ILC2 in asthma. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12212556.","journal-title":"Cells"},{"issue":"6238","key":"9734_CR84","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4\u207a T cells. Sci (New York NY). 2015;348(6238):1031\u20135. https:\/\/doi.org\/10.1126\/science.aaa4812.","journal-title":"Sci (New York NY)"},{"issue":"1","key":"9734_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02023-z","volume":"8","author":"CR Seehus","year":"2017","unstructured":"Seehus CR, Kadavallore A, Torre B, Yeckes AR, Wang Y, Tang J, et al. Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat Commun. 2017;8(1):1900. https:\/\/doi.org\/10.1038\/s41467-017-02023-z.","journal-title":"Nat Commun"},{"key":"9734_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00514","author":"MA Brown","year":"2018","unstructured":"Brown MA, Weinberg RB. Mast cells and innate lymphoid cells: underappreciated players in CNS autoimmune demyelinating disease. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.00514.","journal-title":"Front Immunol"},{"key":"9734_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137076","author":"Y Ahmad","year":"2024","unstructured":"Ahmad Y, Seo DS, Jang Y. Metabolic effects of ketogenic diets: exploring whole-body metabolism in connection with adipose tissue and other metabolic organs. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25137076.","journal-title":"Int J Mol Sci"},{"key":"9734_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1198310","author":"M Sadeghalvad","year":"2023","unstructured":"Sadeghalvad M, Khijakadze D, Orangi M, Takei F. Flow cytometric analysis of innate lymphoid cells: challenges and solutions. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1198310.","journal-title":"Front Immunol"},{"issue":"3","key":"9734_CR89","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10048-014-0403-3","volume":"15","author":"AL Traboulsee","year":"2014","unstructured":"Traboulsee AL, Bernales CQ, Ross JP, Lee JD, Sadovnick AD, Vilari\u00f1o-G\u00fcell C. Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression. Neurogenetics. 2014;15(3):165\u20139. https:\/\/doi.org\/10.1007\/s10048-014-0403-3.","journal-title":"Neurogenetics"},{"key":"9734_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914756","author":"SK Yadav","year":"2023","unstructured":"Yadav SK, Ito K, Dhib-Jalbut S. Interaction of the gut microbiome and immunity in multiple sclerosis: impact of diet and immune therapy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241914756.","journal-title":"Int J Mol Sci"},{"key":"9734_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00217","author":"A Eken","year":"2019","unstructured":"Eken A, Yetkin MF, Vural A, Okus FZ, Erdem S, Azizoglu ZB, et al. Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cells. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.00217.","journal-title":"Front Immunol"},{"issue":"6","key":"9734_CR92","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000157","volume":"2","author":"M Di Dario","year":"2015","unstructured":"Di Dario M, Colombo E, Govi C, De Feo D, Messina MJ, Romeo M, et al. Myeloid cells as target of fingolimod action in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2015;2(6):e157. https:\/\/doi.org\/10.1212\/NXI.0000000000000157.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"9734_CR93","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s13311-021-01078-7","volume":"18","author":"SC Schwichtenberg","year":"2021","unstructured":"Schwichtenberg SC, Wisgalla A, Schroeder-Castagno M, Alvarez-Gonz\u00e1lez C, Schlickeiser S, Siebert N, et al. Fingolimod therapy in multiple sclerosis leads to the enrichment of a subpopulation of aged NK cells. Neurotherapeutics. 2021;18(3):1783\u201397. https:\/\/doi.org\/10.1007\/s13311-021-01078-7.","journal-title":"Neurotherapeutics"},{"issue":"1_Supplement","key":"9734_CR94","doi-asserted-by":"publisher","first-page":"41.10","DOI":"10.4049\/jimmunol.200.Supp.41.10","volume":"200","author":"A Eken","year":"2018","unstructured":"Eken A, Yetkin MF, Okus FZ, Erdem S, Cakir M, Vural A, et al. Fingolimod impacts innate lymphoid cell biology. J Immunol. 2018;200(1_Supplement):41.10\u201341.10. https:\/\/doi.org\/10.4049\/jimmunol.200.Supp.41.10.","journal-title":"J Immunol"},{"issue":"9","key":"9734_CR95","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1134\/S0006297918090110","volume":"83","author":"VS Gogoleva","year":"2018","unstructured":"Gogoleva VS, Atretkhany KSN, Drutskaya MS, Mufazalov IA, Kruglov AA, Nedospasov SA. Cytokines as mediators of neuroinflammation in experimental autoimmune encephalomyelitis. Biochem (Moscow). 2018;83(9):1089\u2013103. https:\/\/doi.org\/10.1134\/S0006297918090110.","journal-title":"Biochem (Moscow)"},{"issue":"1","key":"9734_CR96","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e6","volume":"24","author":"HY Kim","year":"2024","unstructured":"Kim HY, Jeong D, Kim JH, Chung DH. Innate Type-2 Cytokines: from immune regulation to therapeutic targets. Immune Netw. 2024;24(1):e6. https:\/\/doi.org\/10.4110\/in.2024.24.e6.","journal-title":"Immune Netw"},{"issue":"9","key":"9734_CR97","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/s41591-024-03115-2","volume":"30","author":"D Tatovic","year":"2024","unstructured":"Tatovic D, Marwaha A, Taylor P, Hanna SJ, Carter K, Cheung WY, et al. Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Nat Med. 2024;30(9):2657\u201366. https:\/\/doi.org\/10.1038\/s41591-024-03115-2.","journal-title":"Nat Med"},{"key":"9734_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02972","author":"L Vian","year":"2019","unstructured":"Vian L, Le MT, Gazaniga N, Kieltyka J, Liu C, Pietropaolo G, et al. JAK inhibition differentially affects NK cell and ILC1 homeostasis. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.02972.","journal-title":"Front Immunol"},{"issue":"3","key":"9734_CR99","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink JH, Peters CP, Munneke M, Te Velde AA, Meijer SL, Weijer K, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013;14(3):221\u20139. https:\/\/doi.org\/10.1038\/ni.2534.","journal-title":"Nat Immunol"},{"key":"9734_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2015.12.011","volume":"361","author":"SAJ Brod","year":"2016","unstructured":"Brod SAJ. Ingested (oral) anti-IL-12\/23 inhibits EAE. J Neurol Sci. 2016;361:19\u201325. https:\/\/doi.org\/10.1016\/j.jns.2015.12.011.","journal-title":"J Neurol Sci"},{"issue":"41","key":"9734_CR101","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106634118","volume":"118","author":"HB Yu","year":"2021","unstructured":"Yu HB, Yang H, Allaire JM, Ma C, Graef FA, Mortha A, et al. Vasoactive intestinal peptide promotes host defense against enteric pathogens by modulating the recruitment of group 3 innate lymphoid cells. Proc Natl Acad Sci U S A. 2021;118(41):e2106634118. https:\/\/doi.org\/10.1073\/pnas.2106634118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9734_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162617","author":"R di Vito","year":"2022","unstructured":"di Vito R, Conte C, Traina G. A multi-strain probiotic formulation improves intestinal barrier function by the modulation of tight and adherent junction proteins. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11162617.","journal-title":"Cells"},{"key":"9734_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116022","author":"P Chandrasekaran","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of probiotics on gut microbiota: an overview. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25116022.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9734_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0319755","volume":"20","author":"Z Zangeneh","year":"2025","unstructured":"Zangeneh Z, Rostamian M, Motamedi H, Alvandi A, Abiri R. The potential effectiveness of probiotics in reducing multiple sclerosis progression in preclinical and clinical studies: a worldwide systematic review and meta-analysis. PLoS One. 2025;20(4):e0319755. https:\/\/doi.org\/10.1371\/journal.pone.0319755.","journal-title":"PLoS One"},{"key":"9734_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.901846","author":"M Rahimlou","year":"2022","unstructured":"Rahimlou M, Nematollahi S, Husain D, Banaei-Jahromi N, Majdinasab N, Hosseini SA. Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Front Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnins.2022.901846.","journal-title":"Front Neurosci"},{"issue":"4","key":"9734_CR106","doi-asserted-by":"publisher","first-page":"687","DOI":"10.18388\/abp.2020_5597","volume":"68","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang H. Probiotics alleviate inflammatory bowel disease in mice by regulating intestinal microorganisms-bile acid-NLRP3 inflammasome pathway. Acta Biochim Pol. 2021;68(4):687\u201393. https:\/\/doi.org\/10.18388\/abp.2020_5597.","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"9734_CR107","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02124-21","volume":"10","author":"J Wu","year":"2022","unstructured":"Wu J, Lin Z, Wang X, Zhao Y, Zhao J, Liu H, et al. Limosilactobacillus reuteri SLZX19-12 protects the colon from infection by enhancing stability of the gut microbiota and barrier integrity and reducing inflammation. Food Microbiol. 2022;10(3):e02124-21. https:\/\/doi.org\/10.1128\/spectrum.02124-21.","journal-title":"Food Microbiol"},{"issue":"1","key":"9734_CR108","doi-asserted-by":"publisher","first-page":"4400428","DOI":"10.1155\/2021\/4400428","volume":"2021","author":"S Wang","year":"2021","unstructured":"Wang S, Chen H, Wen X, Mu J, Sun M, Song X, et al. The efficacy of fecal microbiota transplantation in experimental autoimmune encephalomyelitis: transcriptome and gut microbiota profiling. J Immunol Res. 2021;2021(1):4400428. https:\/\/doi.org\/10.1155\/2021\/4400428.","journal-title":"J Immunol Res"},{"issue":"1","key":"9734_CR109","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-9255-8-22","volume":"8","author":"AM Miller","year":"2011","unstructured":"Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (London England). 2011;8(1):22. https:\/\/doi.org\/10.1186\/1476-9255-8-22.","journal-title":"J Inflamm (London England)"},{"issue":"1","key":"9734_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor S, Sweeney C, Tubridy N, Mills K. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1\u201311. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04143.x.","journal-title":"Clin Exp Immunol"},{"key":"9734_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578489","volume":"398","author":"A \u00d6zko\u015far","year":"2025","unstructured":"\u00d6zko\u015far A, \u00d6ktelik FB, Gelmez MY, Erden S\u00d6, G\u00fcnd\u00fcz T, K\u00fcrt\u00fcnc\u00fc M, et al. Retinoic acid modulates peripheral blood helper innate lymphoid cell composition in vitro in patients with multiple sclerosis. J Neuroimmunol. 2025;398:578489. https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578489.","journal-title":"J Neuroimmunol"},{"key":"9734_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1540263","volume":"16","author":"C Prado","year":"2025","unstructured":"Prado C, Herrada AA, Hevia D, Goiry LG, Escobedo N. JFiI. Role of innate immune cells in multiple sclerosis. Front Immunol. 2025;16:1540263. https:\/\/doi.org\/10.3389\/fimmu.2025.1540263.","journal-title":"Front Immunol"},{"issue":"6","key":"9734_CR113","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146006","volume":"6","author":"LM Cobb","year":"2021","unstructured":"Cobb LM, Verneris MR. Therapeutic manipulation of innate lymphoid cells. JCI Insight. 2021;6(6):e146006. https:\/\/doi.org\/10.1172\/jci.insight.146006.","journal-title":"JCI Insight"},{"issue":"1","key":"9734_CR114","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126766","volume":"6","author":"B Baban","year":"2021","unstructured":"Baban B, Braun M, Khodadadi H, Ward A, Alverson K, Malik A, et al. AMPK induces regulatory innate lymphoid cells after traumatic brain injury. JCI Insight. 2021;6(1):e126766. https:\/\/doi.org\/10.1172\/jci.insight.126766.","journal-title":"JCI Insight"},{"issue":"1","key":"9734_CR115","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imr.12948","volume":"301","author":"P Ruibal","year":"2021","unstructured":"Ruibal P, Voogd L, Joosten SA, Ottenhoff TH. The role of donor-unrestricted T\u2010cells, innate lymphoid cells, and NK cells in anti\u2010mycobacterial immunity. Immunol Rev. 2021;301(1):30\u201347. https:\/\/doi.org\/10.1111\/imr.12948.","journal-title":"Immunol Rev"},{"issue":"5","key":"9734_CR116","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/mi.2016.64","volume":"9","author":"FF Almeida","year":"2016","unstructured":"Almeida FF, Belz GT. Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. Mucosal Immunol. 2016;9(5):1103\u201312. https:\/\/doi.org\/10.1038\/mi.2016.64.","journal-title":"Mucosal Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09734-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T01:34:29Z","timestamp":1770946469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09734-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9734"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09734-2","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this work, the authors used [Perplexity and Paperpal] to [to improve language, style and readability]. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}